Maxim Group Reiterates Buy Rating on BRAI
Maxim Group maintains its buy rating on BRAI with a $10 price target, a 30.89% upside from the current price.
Key Points
- Maxim Group analyst Allen Klee reiterated a buy rating for BRAI on June 15, 2026, setting a price target of $10.
- Maxim Group's $10 price target implies 30.89% upside from Braiin Limited's ($BRAI) current $7.64 share price.
- Shares of BRAI are trading at $7.64, with no exchange information provided.
- Morgan Stanley and Royal Bank of Canada are among institutional investors holding shares in BRAI.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Maxim Group analyst Allen Klee has reiterated a buy rating for BRAI, maintaining a price target of $10. This reaffirmation came on June 15, 2026, as the stock traded at $7.64.
Other Institutional Activity in BRAI
Morgan Stanley grew its holdings by 2,400 shares, ending with 2,400 shares worth about $16,704. Similarly, Royal Bank of Canada added 495 shares, bringing its total to 495 shares valued at approximately $3,000. Tower Research Capital LLC (TRC) also made a small addition, increasing its position by 3 shares to hold 3 shares worth $21.
Analysts Set New Price Targets
On June 15, 2026, Maxim Group reiterated its buy rating on BRAI, setting a price target of $10. This reflects the firm's positive outlook on the stock.
About BRAI
Details about BRAI's operations, sector, or industry were not provided in the fundamentals data. However, the company continues to attract attention from analysts and institutional investors.
Bottom Line
Maxim Group's reaffirmation of a buy rating with a $10 target highlights continued confidence in BRAI. While the current trading price is $7.64, the reiterated target suggests potential upside. Institutional investors like Morgan Stanley and Royal Bank of Canada are also maintaining positions in the company.
Get Braiin Limited alerts
New 13F filings, insider trades, and analyst moves on $BRAI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.